InvestorsHub Logo

antihama

03/02/18 9:29 AM

#2081 RE: antihama #2080

Yikes, what I said is not accurate. While it's true that a biosim to Neulasta will have interchangeable issues with Neulasta, Rolontis will be competing with Neulasta directly. Mano a mano. Drop the price 30% compared to Neulasta, a non-inferior product, and get oodles of sales.